NovoLog Mix 70/30 U-100 (100 units/mL) injection Images
Generic Name: insulin aspart/insulin aspart protamine
This medication has been identified as NovoLog Mix 70/30 U-100 (100 units/mL) injection. It is supplied by Novo Nordisk.
NovoLog Mix 70/30 is used in the treatment of Diabetes, Type 2; Diabetes, Type 1 and belongs to the drug class insulin. There is no proven risk in humans during pregnancy. NovoLog Mix 70/30 U-100 (100 units/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
NovoLog Mix 70/30
- Generic Name
- insulin aspart/insulin aspart protamine
- Strength
- U-100 (100 units/mL) injection
- Availability
- Prescription only
- Drug Class
- Insulin
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-3685
More about NovoLog Mix 70/30 (insulin aspart/insulin aspart protamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: insulin
- En español
Patient resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
